Surmodics, Inc. is a healthcare company based in the United States that specializes in surface modification and in vitro diagnostic technologies. With a risk rating score of 28.0, the company is considered to be of medium risk. Surmodics focuses on improving disease treatment and detection by providing solutions to challenging medical device and diagnostic issues. The company operates through two segments: Medical device unit, which manufactures performance coatings for medical devices, and Vitro diagnostics unit, which develops chemical and biological components for in vitro diagnostic tests. Surmodics generates most of its revenue from the Medical Device segment.